Waning of mRNA Boosters after Homologous Primary Series with BNT162b2 or ChadOx1 Against Symptomatic Infection and Severe COVID-19 in Brazil and Scotland: A Test-Negative Design Case-Control Study (2022)

First Author: Cerqueira-Silva T
Attributed to:  Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.4082927

Publication URI: http://dx.doi.org/10.2139/ssrn.4082927

Type: Journal Article/Review

Parent Publication: SSRN Electronic Journal